Entries by Morgana Souza
Johnson & Johnson’s COVID-19 candidate enters third trial phase
The company will become the first to test the simpler regimen of its candidate which is being developed by Janssen Pharmaceutical Companies, Dr. Dan Barouch, director of the Center for […]
Johnson & Johnson Begins Large Trial of Its One-Shot Vaccine
Unlike some of its competitors, Johnson & Johnson’s vaccine does not need to be frozen and may require just one shot instead of two. Read Article
J&J kicks off final study of single-shot COVID-19 vaccine in 60,000 volunteers
“The benefits of a single-shot vaccine are potentially profound in terms of mass immunization campaigns and global pandemic control,” Dr. Dan Barouch. Read Article
Major study to start for COVID-19 vaccine developed by Johnson & Johnson, Beth Israel
Up to 60,000 volunteers, including some in Boston, will take part in the trial following encouraging data from more limited testing. Read Article
A single-shot coronavirus vaccine from Johnson & Johnson will be tested in 60,000 people
Three other candidates have a head start, but J&J’s vaccine could be easier to administer and distribute if it is proved safe and effective. Read Article
As Fall Arrives and Pressures Mount, Harvard Medical Researchers Press Forward on Two COVID Vaccine Trials
Beth Israel Deaconess Medical Center, a Harvard Medical School teaching hospital, Dan H. Barouch is heading a COVID-19 vaccine effort in a partnership with pharmaceutical company Johnson & Johnson. Read […]
Vector-Based Vaccines Come to the Fore in the COVID-19 Pandemic
Adenovirus vectors deliver the genetic instructions for SARS-CoV-2 antigens directly into patients’ cells, provoking a robust immune response. But will pre-existing immunity from common colds take them down? Read Article […]
The big question over a Covid vaccine: Is it coming too fast to be trusted?
Dr Kathryn Stephenson, director of the Clinical Trials Unit for the Centre for Virology and Vaccine Research at Harvard University’s Beth Israel Deaconess Medical Centre, told The Independent that the vaccine […]
